Cargando…
Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021
OBJECTIVES: In the early stages of the coronavirus disease 2019 (COVID-19) pandemic, chloroquine and its derivatives such as hydroxychloroquine (HCQ) were widely commented upon both within the scientific community and in the media. This paper explores the different factors that influenced public per...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801974/ https://www.ncbi.nlm.nih.gov/pubmed/35101281 http://dx.doi.org/10.1016/j.therap.2022.01.008 |
_version_ | 1784642573083607040 |
---|---|
author | Schultz, Émilien Atlani-Duault, Laëtitia Peretti-Watel, Patrick Ward, Jeremy K. |
author_facet | Schultz, Émilien Atlani-Duault, Laëtitia Peretti-Watel, Patrick Ward, Jeremy K. |
author_sort | Schultz, Émilien |
collection | PubMed |
description | OBJECTIVES: In the early stages of the coronavirus disease 2019 (COVID-19) pandemic, chloroquine and its derivatives such as hydroxychloroquine (HCQ) were widely commented upon both within the scientific community and in the media. This paper explores the different factors that influenced public perceptions in France of the efficacy of HCQ as well as their evolution between April 2020 and June 2021. METHODS: This article draws on 5 surveys conducted among representative samples of the French population (projects COCONEL and TRACTRUST; quota method, n = 1006; 1004; 2006; 1014 and 1005). We asked questions on the effectiveness of chloroquine against COVID-19. We also collected sociodemographic variables and attitudes toward politics and science. RESULTS: Between April and June 2021, the proportion of respondents who believed in the efficacy of HCQ decreased rapidly from 35% to 14%. The proportion of respondents who believed that HCQ is ineffective rose gradually from 6% to 21%. After adjusting for the temporal effect, the logistic regression showed a very strong association between political orientation and the belief in the efficacy of HCQ. Respondents who felt closest to the more radical parties (far-right and far-left) were more likely to believe in the efficacy of HCQ than those who felt closest to the political center (O.R. 2.48 [1.95–3.15] and 1.87 [1.44–2.43]). The role of trust in the government and in science and of the degree of political engagement were investigated in the two waves conducted after the scientific consensus was established during the summer of 2020. High levels of trust in the government and in science and of politicization are associated with belief of HCQ proven inefficacy. Across the whole period, a majority of respondents were uncertain. Even in 2021, 41.5% stated that the data were insufficient to decide whether or not HCQ is effective and 25.2% stating that they did not know. CONCLUSION: Because media coverage of scientific controversies is higher in times of uncertainty than after these controversies have died down, the publicization of therapeutic promises can have lasting consequences on attitudes towards science and medicine. |
format | Online Article Text |
id | pubmed-8801974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The Author(s). Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88019742022-01-31 Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021 Schultz, Émilien Atlani-Duault, Laëtitia Peretti-Watel, Patrick Ward, Jeremy K. Therapie Social Pharmacology OBJECTIVES: In the early stages of the coronavirus disease 2019 (COVID-19) pandemic, chloroquine and its derivatives such as hydroxychloroquine (HCQ) were widely commented upon both within the scientific community and in the media. This paper explores the different factors that influenced public perceptions in France of the efficacy of HCQ as well as their evolution between April 2020 and June 2021. METHODS: This article draws on 5 surveys conducted among representative samples of the French population (projects COCONEL and TRACTRUST; quota method, n = 1006; 1004; 2006; 1014 and 1005). We asked questions on the effectiveness of chloroquine against COVID-19. We also collected sociodemographic variables and attitudes toward politics and science. RESULTS: Between April and June 2021, the proportion of respondents who believed in the efficacy of HCQ decreased rapidly from 35% to 14%. The proportion of respondents who believed that HCQ is ineffective rose gradually from 6% to 21%. After adjusting for the temporal effect, the logistic regression showed a very strong association between political orientation and the belief in the efficacy of HCQ. Respondents who felt closest to the more radical parties (far-right and far-left) were more likely to believe in the efficacy of HCQ than those who felt closest to the political center (O.R. 2.48 [1.95–3.15] and 1.87 [1.44–2.43]). The role of trust in the government and in science and of the degree of political engagement were investigated in the two waves conducted after the scientific consensus was established during the summer of 2020. High levels of trust in the government and in science and of politicization are associated with belief of HCQ proven inefficacy. Across the whole period, a majority of respondents were uncertain. Even in 2021, 41.5% stated that the data were insufficient to decide whether or not HCQ is effective and 25.2% stating that they did not know. CONCLUSION: Because media coverage of scientific controversies is higher in times of uncertainty than after these controversies have died down, the publicization of therapeutic promises can have lasting consequences on attitudes towards science and medicine. The Author(s). Published by Elsevier Masson SAS on behalf of Société française de pharmacologie et de thérapeutique. 2022 2022-01-17 /pmc/articles/PMC8801974/ /pubmed/35101281 http://dx.doi.org/10.1016/j.therap.2022.01.008 Text en © 2022 The Author(s) Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Social Pharmacology Schultz, Émilien Atlani-Duault, Laëtitia Peretti-Watel, Patrick Ward, Jeremy K. Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021 |
title | Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021 |
title_full | Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021 |
title_fullStr | Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021 |
title_full_unstemmed | Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021 |
title_short | Does the public know when a scientific controversy is over? Public perceptions of hydroxychloroquine in France between April 2020 and June 2021 |
title_sort | does the public know when a scientific controversy is over? public perceptions of hydroxychloroquine in france between april 2020 and june 2021 |
topic | Social Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801974/ https://www.ncbi.nlm.nih.gov/pubmed/35101281 http://dx.doi.org/10.1016/j.therap.2022.01.008 |
work_keys_str_mv | AT schultzemilien doesthepublicknowwhenascientificcontroversyisoverpublicperceptionsofhydroxychloroquineinfrancebetweenapril2020andjune2021 AT atlaniduaultlaetitia doesthepublicknowwhenascientificcontroversyisoverpublicperceptionsofhydroxychloroquineinfrancebetweenapril2020andjune2021 AT perettiwatelpatrick doesthepublicknowwhenascientificcontroversyisoverpublicperceptionsofhydroxychloroquineinfrancebetweenapril2020andjune2021 AT wardjeremyk doesthepublicknowwhenascientificcontroversyisoverpublicperceptionsofhydroxychloroquineinfrancebetweenapril2020andjune2021 |